Amy Reeves
Nessuna posizione attualmente
Patrimonio netto: 15 260 $ in data 31/03/2024
Profilo
Amy S.
Reeves worked as the Global Controller at Wright Medical Group NV from 2019 to 2021.
She then became the Chief Financial Officer at View, Inc. in 2021, where she will work until 2024.
Reeves received both undergraduate and graduate degrees from the University of Mississippi.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VIEW INC. CLASS A
0.33% | 08/01/2024 | 13 270 ( 0.33% ) | 15 261 $ | 31/03/2024 |
Precedenti posizioni note di Amy Reeves
Società | Posizione | Fine |
---|---|---|
VIEW, INC. | Director of Finance/CFO | 02/02/2024 |
WRIGHT MEDICAL GROUP N.V. | Comptroller/Controller/Auditor | 01/06/2021 |
Formazione di Amy Reeves
University of Mississippi | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VIEW, INC. | Process Industries |
Aziende private | 1 |
---|---|
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Amy Reeves